Laticom-SP Tablet is a combination analgesic and anti-inflammatory medication containing Aceclofenac (100 mg), Paracetamol (325 mg), and Serratiopeptidase (15 mg). Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), exerts potent anti-inflammatory and analgesic effects by inhibiting cyclooxygenase enzymes, thereby reducing prostaglandin synthesis. Paracetamol provides effective analgesia and antipyretic action through central inhibition of prostaglandin synthesis, complementing the anti-inflammatory properties of Aceclofenac. Serratiopeptidase, a proteolytic enzyme, facilitates the breakdown of inflammatory mediators and promotes the resolution of inflammation and edema, enhancing tissue repair and recovery. This combination is indicated for the management of acute and chronic musculoskeletal disorders, including osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and soft tissue injuries such as sprains and strains. Laticom-SP Tablet offers symptomatic relief from pain, inflammation, and swelling, improving patient mobility and quality of life. It should be used under medical supervision, considering contraindications such as hypersensitivity to NSAIDs, active gastrointestinal ulcers, and severe hepatic or renal impairment. Caution is advised in patients with cardiovascular risk factors. The dosage and duration of therapy should be individualized based on clinical response and tolerability.